An Indian woman has made it to the annals of history by becoming part of a miracle cancer treatment that had 100 percent success rate in curing patients. Nisha Varghese, an Indian-American rectal cancer patient, was part of the 18-person trial group of rectal cancer patients. According to reports, Varghese has been cured completely after her tumour disappeared, thanks to a revolutionary new drug called Dostarlimab.
The experimental new treatment trial using Dostarlimab was carried out by New York’s Memorial Sloan Kettering Cancer Center. All patients were administered Dostarlimab for six months. Following the treatment, the cancer seemed to have vanished from all patients. This is the first time that any cancer drug trial has exhibited 100 percent success rate.
Speaking to the media about her recovery, Varughese said ‘It’s a miracle’. Varghese and the other patients who were part of the trial were all in similar stages of their cancer – it was locally advanced in the rectum but had not spread to other organs. All had previously faced gruelling treatments to obliterate their cancer including painful chemotherapy, radiation and invasive surgery that could result in bowel, urinary, and even sexual dysfunction.
The 18 patients went into the trial expecting to have to go through these as the next step. However, to their surprise, no further treatment was needed. According to the results of the experiment, published in New England Journal of Medicine, every single patient was cured of cancer, which had not resurfaced in with of them for two years. The paper also noted that unlike other cancer treatments, the immunotherapy adopted by MSK did not have any significant side effects.
